Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
27 June 2017
P-004268-17
Question for written answer
to the Commission
Rule 130
Lampros Fountoulis (NI)

 Subject:  Implications of new pharmaceuticals agreement for cancer patients in Greece
 Answer(s) 

The initial effects of the new pharmaceuticals agreement are now being felt in Greece following the adoption of Law 4472/17 under the terms of the new memorandum, stipulating that, before next-generation medicines can be administered to Greek cancer sufferers, they must have been previously approved in nine European countries, be reimbursed in six and have undergone health technology assessment, which is not currently available in Greece, in three countries.(1),(2).

The provisions of this recent law are effectively denying Greek patients access to new medicines(3) that might offer a cure or increase their life expectancy, thereby depriving them of the same treatment as other European patients.

In view of this:
1. Is the Commission aware of the agreement and its implications for the health of patients and possibly their chances of survival?
2. Does it consider it admissible for individuals to be literally sacrificed to the economic adjustment programme and does it approve of the restrictions being imposed?
3. If not, will it propose alternative solutions to ensure that economic measures do not affect public health?

(1) http://www.healthreport.gr/%CF%84%CE%AD%CE%BB%CE%BF%CF%82-%CF%83%CF%84%CE%B1-%CF%86%CE%AC%CF%81%CE%BC%CE%B1%CE%BA%CE%B1-%CE%BD%CE%AD%CE%B1%CF%82-%CE%B3%CE%B5%CE%BD%CE%B9%CE%AC%CF%82-%CE%B3%CE%B9%CE%B1-%CE%BA%CE%B1%CF%81%CE%BA/
(2) https://newreport.gr/%CF%85%CE%B3%CE%B5%CE%B9%CE%B1/60891/protes-epiptoseis-tou-mnimoniou-telos-sta-farmaka-neas-genias-gia-karkinopatheis/
(3) https://reportal.gr/2017/06/05/%CE%AC%CF%83%CF%87%CE%B7%CE%BC%CE%B1-%CE%BD%CE%AD%CE%B1-%CE%B3%CE%B9%CE%B1-%CF%84%CE%BF%CF%85%CF%82-%CE%BA%CE%B1%CF%81%CE%BA%CE%B9%CE%BD%CE%BF%CF%80%CE%B1%CE%B8%CE%B5%CE%AF%CF%82-%CF%80%CE%BB%CE%AD/

Original language of question: EL 
Last updated: 4 July 2017Legal notice